Documents show that Richard Sackler was especially involved in the company's efforts to market the drug, and that he pushed staff to pursue OxyContin's deregulation in Germany.

The deposition also reveals that Sackler pushed company officials to find out if German officials could be persuaded to loosen restrictions on the selling of OxyContin. In most countries, narcotic pain relievers are regulated as "controlled" substances because of the potential for abuse. Sackler and other Purdue executives discussed the possibility of persuading German officials to classify OxyContin as an uncontrolled drug, which would likely allow doctors to prescribe the drug more readily—for instance, without seeing a patient. Fewer rules were expected to translate into more sales, according to company documents disclosed at the deposition.
https://psmag.com/social-justice/purdue-pharma-misled-people-about-the-strength-of-oxyc...

Und wer hat diesen Verbrechern dabei geholfen?
McKinsey Advised Purdue Pharma How to ‘Turbocharge’ Opioid Sales
https://www.nytimes.com/2019/02/01/business/purdue-pharma-mckinsey-oxycontin-opiods.html

--
Ein ueberragender Teil der Oekonomen, Politiker, Banker, Analysten und Journalisten ist einfach unfaehig, Bitcoin richtig zu verstehen, weil es so revolutionaer ist.
Info:
www.tinyurl.com/y97d87xk
www.tinyurl.com/yykr2zv2